The Oncology Institute Rebrands as Starling Oncology
Globe Newswire (Mon, 3-Aug 8:00 AM ET)
The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Globe Newswire (Mon, 27-Jul 9:00 AM ET)
Globe Newswire (Tue, 7-Jul 9:00 AM ET)
Globe Newswire (Tue, 26-May 9:00 AM ET)
Market Chameleon (Fri, 13-Mar 6:31 AM ET)
Market Chameleon (Fri, 14-Nov 5:30 AM ET)
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
Starling Oncology trades on the NASDAQ stock market under the symbol TOI.
As of August 13, 2026, TOI stock price was flat at $5.13 with million shares trading.
TOI has a beta of 1.78, meaning it tends to be more sensitive to market movements. TOI has a correlation of 0.08 to the broad based SPY ETF.
TOI has a market cap of $512.91 million. This is considered a Small Cap stock.
In the last 3 years, TOI traded as high as $6.67 and as low as $.13.
The top ETF exchange traded funds that TOI belongs to (by Net Assets): VTI, VXF, VTWO, VHT, VTWG.
TOI has outperformed the market in the last year with a price return of +24.8% while the SPY ETF gained +22.2%. TOI has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.6% and +7.5%, respectively, while the SPY returned +5.6% and +6.6%, respectively.
TOI support price is $4.89 and resistance is $5.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TOI shares will trade within this expected range on the day.